Futura Strikes Deal With Menarini To Commercialize MED3000 ED Gel In South Korea

South Korean erectile dysfunction sufferers may soon be able to acess Futura Medical's drug-free MED3000 treatment thanks to a deal with Menarini Korea Limited, a wholly owned subsidiary of Italy’s Menarini Group, for exclusive commercialization rights in the country. 

Flag of South Korea flies in front of a blue sky
• Source: Shutterstock

Menarini Korea Limited, a wholly owned subsidiary of Italy’s Menarini Group, has struck a deal with UK R&D specialist Futura Medical plc for the exclusive rights to commercialize the latter’s topical, gel-based erectile dysfunction treatment MED3000 in South Korea.

Under the terms of the agreement, Menarini will be responsible for all local MED3000 development, regulatory approvals, product launch and marketing,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

Eisai Switches Proton Pump Inhibitor Rabeprazole To OTC In Japan

 
• By 

Eisai aims to support people in Japan with severe heartburn and discomfort caused by gastric acid related conditions by switching from prescription to OTC status its Pariet-branded proton pump inhibitor.

Thai TikTok Boom Driving Double-Digit Growth In Southeast Asia’s Dietary Supplements Market

 
• By 

TikTok dietary supplement sales in Thailand grew by an astonishing 635% in 2024, while sales via Vietnam's and Malaysia's traditional e-commerce platforms increased by a still impressive 73% and 83% respectively.

Haleon Completes Deal To Grow Stake In China JV

 
• By 

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

APAC Congress: Regulators And Industry Agree ‘Bangkok Joint Initiative on Self-Care’

 
• By 

Organizations representing APAC health and medicines regulators and the consumer health industry respectively have agreed to “recognize the importance of self-care as a fundamental pillar of health and wellbeing” and “affirm our dedication to advancing self-care as an essential component of Universal Health Coverage.”

More from Geography

US Tariffs Pose ‘Existential Threat’ To EU Medical Devices Industry

 
• By 

AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.

OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By 

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By 

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.